MinYaoMD

Radiation Oncology • Cleveland, OH

Associate Professor of Radiation Oncology, Case West Res University

Join to view full profile

Dr. Yao is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Yao's full profile

Already have an account?

Office
11100 Euclid Ave
Cleveland, OH 44106
Phone+1 216-844-3951

Education & Training

University of RochesterResidency, Radiation Oncology, 1998 - 2002
Mercy Catholic Medical CenterInternship, Transitional Year, 1997 - 1998
Sun Yat-Sen University of Medical ScienceClass of 1984

Certifications & Licensure

TX State Medical License 2008 - 2026
OH State Medical License 2008 - 2025
PA State Medical License 1997 - 2024
IA State Medical License 2002 - 2009
American Board of Radiology Radiation Oncology

Clinical Trials

Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Start of enrollment: 2008 Dec 01
Completed
Phase 2
RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Start of enrollment: 2010 Mar 31
Active, not recruiting
Phase 3
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Completed
Phase 3
The Addition of Pembrolizumab to Postoperative Radiotherapy in Cutaneous Squamous Cell Cancer of the Head and Neck Start of enrollment: 2017 May 10
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

25 citations
Neoadjuvant Chemoimmunotherapy for the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm Phase 2 Clinical Trial.
Zhanjie Zhang, Bian Wu, Gang Peng, Guixiang Xiao, Jing Huang
Clinical Cancer Research. 2022-08-02
4 citations
Chemoradiotherapy-related carotid artery inflammation in head and neck cancer patients quantified by [18F]FDG PET/CT
Xuguang Chen, Y. Zheng, Curtis Tatsuoka, Raymond F. Muzic, Christian C. Okoye
Oral Oncology. 2019-06-01
19 citations
ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck.
Shlomo A. Koyfman, Jay S. Cooper, Jonathan J. Beitler, Paul M. Busse, Christopher U. Jones
Head & Neck. 2016-02-01

Press Mentions

University Hospitals Seidman Cancer Center Enrolls First Patient in New National Head and Neck Cancer StudyFebruary 23rd, 2017